drugset / Trial / NCT03491995
A Unique Regimen for Treatment of Helicobacter Pylori Infection
RandomizedParallel-groupTriple-blindTreatment
Summary
The triple treatment including Proton pump inhibitor (PPI) -clarithromycin and amoxicillin or metronidazole was proposed 30 years ago at the first Maastricht conference to treat helicobacter pylori (H. pylori) infection and since that time, it has become the universal and standard treatment for helicobacter pylori. However, the efficacy of this triple regimen has been seriously challenged, and they are gradually becoming ineffective
Timeline
- Start
- 2018-04-01
- Primary completion
- 2023-04-01
- Completion
- 2023-04-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Amoxicillin | Other / unclassified | — | — |
| Subject | Clarithromycin | Small molecule | — | — |
| Subject | Doxycycline | Small molecule | — | — |
| Subject | Moxifloxacin | Small molecule | — | — |
| Subject | Nitazoxanide | Other / unclassified | — | — |
| Background | Omeprazole | Other / unclassified | — | — |